KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Construction in Progress (2016 - 2025)

Historic Construction in Progress for National Health Investors (NHI) over the last 15 years, with Q3 2025 value amounting to $12.5 million.

  • National Health Investors' Construction in Progress rose 1002.74% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 1002.74%. This contributed to the annual value of $10.6 million for FY2024, which is 7872.48% up from last year.
  • Latest data reveals that National Health Investors reported Construction in Progress of $12.5 million as of Q3 2025, which was up 1002.74% from $8.3 million recorded in Q2 2025.
  • National Health Investors' 5-year Construction in Progress high stood at $12.5 million for Q3 2025, and its period low was $468000.0 during Q4 2021.
  • Its 5-year average for Construction in Progress is $5.6 million, with a median of $5.9 million in 2023.
  • As far as peak fluctuations go, National Health Investors' Construction in Progress crashed by 8486.91% in 2021, and later surged by 61623.93% in 2022.
  • Over the past 5 years, National Health Investors' Construction in Progress (Quarter) stood at $468000.0 in 2021, then surged by 616.24% to $3.4 million in 2022, then soared by 76.4% to $5.9 million in 2023, then skyrocketed by 78.72% to $10.6 million in 2024, then grew by 17.95% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q3 2025, $8.3 million for Q2 2025, and $6.7 million during Q1 2025.